Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Narpala

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Journal of Virology|March 6, 2015
Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 EnvIvelin S Georgiev, M Gordon Joyce, Yongping Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2022
Early human B cell signatures of the primary antibody response to mRNA vaccinationLela Kardava, Nicholas Rachmaninoff, William W Lau, et al.
Cell Reports|December 7, 2017
Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 StrainsM Gordon Joyce, Ivelin S Georgiev, Yongping Yang, et al.
Open Forum Infectious Diseases|March 10, 2023
Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy TrialDean Follmann, Holly E Janes, Eric Chu, et al.
BMJ Open|August 28, 2023
Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trialSharana Mahomed, Nigel Garrett, Disebo Potloane, et al.
Frontiers in Immunology|December 30, 2022
Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settingsKristin L Boswell, Timothy A Watkins, Evan M Cale, et al.
Journal of Virology|July 8, 2011
Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimenNicola Winstone, Aaron J Wilson, Gavin Morrow, et al.
Journal of Virology|April 17, 2020
Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited ResponsesGwo-Yu Chuang, Yen-Ting Lai, Jeffrey C Boyington, et al.
Science Translational Medicine|April 19, 2023
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humansSarah F Andrews, Lauren Y Cominsky, Geoffrey D Shimberg, et al.
Science Translational Medicine|January 3, 2024
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primatesMadhu Prabhakaran, Flavio Matassoli, David Leggat, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of Virology|March 6, 2015
Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 EnvIvelin S Georgiev, M Gordon Joyce, Yongping Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2022
Early human B cell signatures of the primary antibody response to mRNA vaccinationLela Kardava, Nicholas Rachmaninoff, William W Lau, et al.
Cell Reports|December 7, 2017
Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 StrainsM Gordon Joyce, Ivelin S Georgiev, Yongping Yang, et al.
Open Forum Infectious Diseases|March 10, 2023
Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy TrialDean Follmann, Holly E Janes, Eric Chu, et al.
BMJ Open|August 28, 2023
Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trialSharana Mahomed, Nigel Garrett, Disebo Potloane, et al.
Frontiers in Immunology|December 30, 2022
Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settingsKristin L Boswell, Timothy A Watkins, Evan M Cale, et al.
Journal of Virology|July 8, 2011
Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimenNicola Winstone, Aaron J Wilson, Gavin Morrow, et al.
Journal of Virology|April 17, 2020
Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited ResponsesGwo-Yu Chuang, Yen-Ting Lai, Jeffrey C Boyington, et al.
Science Translational Medicine|April 19, 2023
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humansSarah F Andrews, Lauren Y Cominsky, Geoffrey D Shimberg, et al.
Science Translational Medicine|January 3, 2024
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primatesMadhu Prabhakaran, Flavio Matassoli, David Leggat, et al.
Pageof 5